Latest Choroideremia Stories
Companies to explore potential of Clearside's microinjector technology for use in delivering gene therapeutics to the retina and choroid through the suprachoroidal space PHILADELPHIA,
Carlsbad Eye Care ophthalmologist Dr.
Program leverages experience with lead Phase 3 program in inherited retinal dystrophies (IRDs) and expands relationship with the Center for Retinal and Ocular Therapy at the University of Pennsylvania
Foundation Fighting Blindness Co-Founder and Chairman Gordon Gund and Family to Catalyze Retinal Degenerative Disease Research with Unlimited Donation Matching Challenge for Two Years
A new genetic therapy for a type of inherited blindness called choroideremia is showing promise and allowing patients to see more than they could before the treatment.
Researchers at Ohio State University Medical Center and Nationwide Children’s Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
Research lead by Dr. Nicolas Bazan, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.